PATENT CLAIM ANALYSIS

Application Number: 16226430
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "231000"]

Abstract:
Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.

Claim (Index 3):
The pharmaceutical composition of  claim 1 , wherein the dosage form is in a tablet.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.10526
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15918852', '14452296', '13869520', '14712630', '14712582']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466386232404748
- 35 USC 102 Novelty (BERT): 0.5002747028825212
- Combined Prediction Score: 0.7220022312046795
- Mean Citation Score: 224.65
- Max Citation Score: 232.41478
- Similarity Product: 167.60501374117848

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test